Australia markets closed

Elevation Oncology, Inc. (ELEV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.7700+0.0300 (+0.80%)
As of 09:30AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
24,153
25,434
78,717
23,595
15,476
Selling general and administrative
14,416
14,904
15,832
8,451
1,800
Total operating expenses
38,569
40,338
94,549
32,046
17,276
Operating income or loss
-38,569
-40,338
-94,549
-32,046
-17,276
Interest expense
-
4,200
1,500
-
-
Total other income/expenses net
-871
-5,036
-6
7
11
Income before tax
-39,316
-45,674
-95,055
-32,039
-17,265
Income tax expense
36
30
25
0
-
Income from continuing operations
-39,352
-45,704
-95,080
-32,039
-17,265
Net income
-39,352
-45,704
-95,080
-32,039
-17,265
Net income available to common shareholders
-39,352
-45,704
-95,080
-32,039
-17,265
Basic EPS
-2.03
-
-4.09
-2.64
-1.04
Diluted EPS
-2.03
-
-4.09
-2.64
-1.04
Basic average shares
29,276
-
23,267
12,133
16,537
Diluted average shares
29,276
-
23,267
12,133
16,537